Orthotopic breast tumor models

ZX Zhijie Xu
ZZ Zhiyang Zhou
XY Xiaoxin Yang
AT Abhimanyu Thakur
NH Ning Han
HL Hai-Tao Li
LL Liu-Gen Li
JH Jun Hu
TL Tong-fei Li
YY Yuanliang Yan
ask Ask a question
Favorite

The murine breast carcinoma 4T1 cells were cultured in Dulbecco’s modified Eagle’s medium (Biological Industries, Israel) containing 10% fetal bovine serum and incubated under the atmosphere with 5% CO2 at 37℃. Five-week-old female BALB/c mice were purchased from Hunan Sleck Jingda Laboratory Animal Company Limited. Appropriately 2 × 106 4T1 cells were injected into the right mammary fat pad to establish an orthotopic breast tumor model. In another orthotopic tumor model, primary tumors were generated by orthotopic implantation of 2 × 106 MDA-MB-231 cells in the mammary fat pad of CB-17 SCID female mice. When tumors in these models reached the determined size (approximate 50 mm3), mice were randomly assigned to different treatment groups: (I) control groups, (II) Fe-MOF groups, (III) PAZ groups, and (IV) PAZ@Fe-MOF groups. Tumor volume was measured every 2 days and calculated using the following equation: volume = (length × width × width)/2. After 27 days of careful monitoring, the mice were euthanized, and the tumors were surgically dissected. Finally, tumor samples were photographed, weighed, and used for the following experimental analysis. The animal experiments were approved by the Ethics Committee of Central South University (No. CSU-2024-0085).

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A